CMG Pharmaceutical Co., Ltd. (KOSDAQ: 058820)

CMG Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2019	FY 2018	FY 2017
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Cash & Equivalents	3,498	1,243	4,456	18,571	13,464	3,799
Short-Term Investments	79,341	67,585	73,357	39,000	41,000	53,000
Trading Asset Securities	-	-	-	62,003	-	249.5
Cash & Short-Term Investments	82,839	68,827	77,813	119,574	54,464	57,049
Cash Growth	9.75%	-11.55%	-34.92%	119.55%	-4.53%	-3.57%
Accounts Receivable	26,813	23,320	21,330	20,291	17,261	15,094
Other Receivables	833.8	929.56	1,143	869.89	445.57	413.79
Receivables	27,647	24,250	34,542	21,161	17,706	15,507
Inventory	18,922	20,570	21,270	9,049	8,573	7,905
Prepaid Expenses	94.56	150.35	143.3	71.04	43.16	31.6
Other Current Assets	3,703	1,940	1,301	729.16	583.76	735.39
Total Current Assets	133,206	115,737	135,070	150,584	81,370	81,227
Property, Plant & Equipment	74,982	50,711	37,472	24,119	17,269	16,183
Long-Term Investments	51,632	52,565	22,996	4,003	4,657	4,154
Goodwill	2,274	2,274	-	-	-	-
Other Intangible Assets	3,134	3,675	3,105	1,339	1,073	988.38
Long-Term Deferred Tax Assets	1,565	2,973	2,603	2,006	2,544	-
Long-Term Deferred Charges	16,363	13,627	11,282	9,736	6,999	6,607
Other Long-Term Assets	328.28	456.59	621.92	455.44	468.23	408.88
Total Assets	304,724	242,098	213,260	192,243	114,380	109,568
Accounts Payable	6,493	9,197	11,245	4,328	4,163	7,002
Accrued Expenses	2,819	3,204	2,917	2,054	1,378	1,123
Short-Term Debt	52,924	880	-	-	-	-
Current Portion of Leases	236.65	206.16	356.41	129.64	-	-
Current Income Taxes Payable	-	-	99.45	-	19.86	-
Other Current Liabilities	20,806	11,042	7,285	2,794	2,935	2,759
Total Current Liabilities	83,278	24,529	21,903	9,306	8,495	10,884
Long-Term Debt	23,200	24,701	6,000	-	-	-
Long-Term Leases	288.32	332.07	356.43	156.76	-	-
Other Long-Term Liabilities	168.91	1,550	48.38	1,565	1,160	808.17
Total Liabilities	108,695	51,866	28,307	12,085	10,398	11,624
Common Stock	69,446	69,446	69,446	69,446	54,444	54,444
Additional Paid-In Capital	104,889	104,641	104,641	104,812	46,786	46,786
Retained Earnings	19,984	14,219	9,000	5,055	2,309	-3,398
Comprehensive Income & Other	1,710	1,926	1,866	845.23	443.09	111.84
Shareholders' Equity	196,030	190,233	184,953	180,158	103,982	97,944
Total Liabilities & Equity	304,724	242,098	213,260	192,243	114,380	109,568
Total Debt	76,649	26,119	6,713	286.39	-	-
Net Cash (Debt)	6,190	42,708	71,100	119,288	54,464	57,049
Net Cash Growth	-87.54%	-39.93%	-40.40%	119.02%	-4.53%	-3.57%
Net Cash Per Share	36.25	307.49	511.91	981.40	500.19	523.21
Filing Date Shares Outstanding	141.1	138.89	138.89	138.89	108.89	108.89
Total Common Shares Outstanding	141.1	138.89	138.89	138.89	108.89	108.89
Working Capital	49,928	91,208	113,167	141,278	72,875	70,343
Book Value Per Share	1389.30	1369.64	1331.63	1297.11	954.95	899.50
Tangible Book Value	190,622	184,284	181,848	178,820	102,909	96,956
Tangible Book Value Per Share	1350.97	1326.81	1309.28	1287.47	945.10	890.42
Land	19,574	3,985	2,709	2,709	2,709	2,709
Buildings	12,312	11,004	10,741	10,741	10,741	10,741
Machinery	19,198	18,421	16,934	14,678	13,589	12,597
Construction In Progress	41,444	34,094	22,579	7,511	1,412	28.14

Source: S&P Capital IQ. Standard template. Financial Sources.